Nl-Fr

View abstract

This abstract is assigned to session Poster session
Title24h IOP control by subchronic AMA0076 in Dutch Belted Rabbits
Abstract Nr.P121
PurposeTo investigate IOP lowering efficacy of rho kinase (ROCK) inhibitors after subchronic treatment.
MethodsDBR (5 rabbits/concentration) were treated daily with a single topical dose of AMA0076 or Y-39983 in a masked fashion for 14 days. Saline was used as control in the contralateral eye. IOP was measured before, 3 and 7 hours after treatment. AMA0076 is a locally acting ROCK inhibitor, developed by Amakem Ophthalmics, to reduce side effects such as hyperemia.
ResultsMean baseline IOP before start of experiment was 21.0 ± 0.4 and 20.7 ± 0.4 mmHg for AMA0076 and Y-39983, respectively. Significant IOP reduction was observed in all treatment groups. A maximal IOP reduction of 39 and 35% was reached with AMA0076 0.1% and Y-39983 0.05%, respectively. Initially, IOP returned to baseline values 24h after administration of AMA0076. After 3 days of treatment with AMA0076 a sustained IOP lowering effect was present: IOP did not return to baseline values, but remained significantly lower for all concentrations of AMA0076. Treatment with Y-39983 did not show this sustained IOP decrease. As a result of this sustained IOP lowering effect smaller IOP fluctuations were observed in animals treated with AMA0076 compared to Y-39983. Hyperemia was observed with all concentrations of Y-39983 whereas only mild hyperemia was induced after administration of AMA0076 0.4.
ConclusionTreatment of rabbits with AMA0076 resulted in IOP reduction that was more sustained and associated with smaller peak-through fluctuations than Y-39983.
Authors 1
Last nameVAN DE VELDE
InitialsS
DepartmentKUL Ophthalmo
Cityleuven
Authors 2
Last nameVan Bergen
InitialsT
DepartmentKUL Ophthalmo
CityLeuven
Authors 3
Last nameHollanders
InitialsK
DepartmentKUL Ophthalmo
CityLeuven
Authors 4
Last nameSijnave
InitialsD
DepartmentKUL Ophthalmo
CityLeuven
Authors 5
Last nameVandewalle
InitialsE
DepartmentKUL Ophthalmo
CityLeuven
Authors 6
Last nameCastermans
InitialsK
DepartmentAmakem Ophthalmics
CityDiepenbeek
Authors 7
Last nameKindt
InitialsN
DepartmentAmakem Ophthalmics
CityDiepenbeek
Authors 8
Last nameMoons
InitialsL
DepartmentKUL Biologie
CityLeuven
Authors 9
Last nameLeysen
DepartmentAmakem Ophthalmics
CityDiepenbeek
Authors 10
Last nameStalmans
InitialsI
DepartmentKUL Ophthalmo
CityLeuven
top ^